- Home
- MRAM vs RAPT Comparison
MRAM vs RAPT Comparison
Compare MRAM & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRAM
- RAPT
- Stock Information
- Founded
- MRAM 2008
- RAPT 2015
- Country
- MRAM United States
- RAPT United States
- Employees
- MRAM N/A
- RAPT N/A
- Industry
- MRAM Semiconductors
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- MRAM Technology
- RAPT Health Care
- Exchange
- MRAM Nasdaq
- RAPT Nasdaq
- Market Cap
- MRAM 114.4M
- RAPT 117.5M
- IPO Year
- MRAM 2016
- RAPT 2019
- Fundamental
- Price
- MRAM $5.61
- RAPT $0.89
- Analyst Decision
- MRAM Strong Buy
- RAPT Buy
- Analyst Count
- MRAM 1
- RAPT 5
- Target Price
- MRAM $8.00
- RAPT $5.25
- AVG Volume (30 Days)
- MRAM 79.4K
- RAPT 1.1M
- Earning Date
- MRAM 04-30-2025
- RAPT 05-08-2025
- Dividend Yield
- MRAM N/A
- RAPT N/A
- EPS Growth
- MRAM N/A
- RAPT N/A
- EPS
- MRAM N/A
- RAPT N/A
- Revenue
- MRAM $49,110,000.00
- RAPT N/A
- Revenue This Year
- MRAM $9.48
- RAPT N/A
- Revenue Next Year
- MRAM $12.85
- RAPT N/A
- P/E Ratio
- MRAM N/A
- RAPT N/A
- Revenue Growth
- MRAM N/A
- RAPT N/A
- 52 Week Low
- MRAM $4.34
- RAPT $0.71
- 52 Week High
- MRAM $7.00
- RAPT $4.60
- Technical
- Relative Strength Index (RSI)
- MRAM 45.63
- RAPT 48.13
- Support Level
- MRAM $5.49
- RAPT $0.81
- Resistance Level
- MRAM $6.25
- RAPT $1.27
- Average True Range (ATR)
- MRAM 0.21
- RAPT 0.14
- MACD
- MRAM -0.08
- RAPT 0.01
- Stochastic Oscillator
- MRAM 15.00
- RAPT 31.55
About MRAM Everspin Technologies Inc.
Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.